196 related articles for article (PubMed ID: 36484959)
21. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
22. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
23. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
Gao P; Lu W; Hu S; Zhao K
Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
[TBL] [Abstract][Full Text] [Related]
24. Identification of Key Genes Involved in Diabetic Peripheral Neuropathy Progression and Associated with Pancreatic Cancer.
Jian L; Yang G
Diabetes Metab Syndr Obes; 2020; 13():463-476. PubMed ID: 32110079
[TBL] [Abstract][Full Text] [Related]
25. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.
Liu J; Li J; Li H; Li A; Liu B; Han L
Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614
[TBL] [Abstract][Full Text] [Related]
26. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
[TBL] [Abstract][Full Text] [Related]
27. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
28. Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes.
Shen J; Zhu B
Mol Med Rep; 2018 Jun; 17(6):7636-7644. PubMed ID: 29620215
[TBL] [Abstract][Full Text] [Related]
29. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
30.
Deng Y; Ma H; Hao J; Xie Q; Zhao R
Biomed Res Int; 2020; 2020():8604340. PubMed ID: 32420375
[TBL] [Abstract][Full Text] [Related]
31. Identification of Biomarkers for Ovarian Cancer Diagnosis and Prognosis by Bioinformatics Analysis and q-PCR Validation.
Zheng Q; Ye H; Zhong H; Wang M
Ann Clin Lab Sci; 2022 Nov; 52(6):967-975. PubMed ID: 36564071
[TBL] [Abstract][Full Text] [Related]
32. Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods.
Li C; Zeng X; Yu H; Gu Y; Zhang W
World J Surg Oncol; 2018 Nov; 16(1):223. PubMed ID: 30428899
[TBL] [Abstract][Full Text] [Related]
33.
Yin M; Zhou L; Ji Y; Lu R; Ji W; Jiang G; Ma J; Song X
Front Endocrinol (Lausanne); 2022; 13():946492. PubMed ID: 35992146
[TBL] [Abstract][Full Text] [Related]
34. Screening of Therapeutic Targets for Pancreatic Cancer by Bioinformatics Methods.
Xiao X; Wan Z; Liu X; Chen H; Zhao X; Ding R; Cao Y; Zhou F; Qiu E; Liang W; Ou J; Chen Y; Chen X; Zhang H
Horm Metab Res; 2023 Jun; 55(6):420-425. PubMed ID: 36599457
[TBL] [Abstract][Full Text] [Related]
35. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
36.
Zhou DY; Mou X; Liu K; Liu WH; Xu YQ; Zhou D
Exp Ther Med; 2020 Nov; 20(5):60. PubMed ID: 32952650
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling and protein-protein network analysis revealed prognostic hub biomarkers linking cancer risk in type 2 diabetic patients.
Kasera H; Shekhawat RS; Yadav P; Singh P
Sci Rep; 2023 Dec; 13(1):22605. PubMed ID: 38114687
[TBL] [Abstract][Full Text] [Related]
38. Screening and Identification of Key Biomarkers in Pancreatic Cancer: Evidence from Bioinformatic Analysis.
Zhang M; Di CY; Guo P; Meng LB; Shan MJ; Qiu Y; Guo PY; Dong KQ; Xie Q; Wang Q
J Comput Biol; 2020 Jul; 27(7):1079-1091. PubMed ID: 31638423
[TBL] [Abstract][Full Text] [Related]
39. Identification of significant genes associated with prognosis of gastric cancer by bioinformatics analysis.
Wang S; Tao S; Liu Y; Shi Y; Liu M
J Egypt Natl Canc Inst; 2022 Dec; 34(1):55. PubMed ID: 36567425
[TBL] [Abstract][Full Text] [Related]
40. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk.
Xue R; Hua L; Xu W; Gao Y; Pang Y; Hao J
Biomed Res Int; 2018; 2018():4283673. PubMed ID: 30519576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
